• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Techcouver.com

 
 
  • News
  • Interviews
  • Thought Leadership
  • Bulletin Board
  • Job Board
  • About
    • Contact Us
  • Advertise

Zymeworks

The Top 25 Healthcare Technology Leaders of Vancouver for 2022

December 29, 2022 by Robert Lewis Leave a Comment

Moove It’s Health Index uses data to reveal the cities with the most developed healthtech ecosystems in the world and the software consulting firm recently ranked Vancouver third among Canadian cities for advancement of their healthtech sectors. Supporting Vancouver’s ranking as a global city leading the technological advancement of healthcare, the Healthcare Technology Report has announced […]

Filed Under: News Tagged With: AbCellera, Acuitas Therapeutics, adMare Bioinnovations, Applied Biological Materials, Arazy Group Consultants, Aurora Cannabis, bioLytical, Canary Medical, Genome BC, Illumina, Interactive Health International, Jazz Pharmaceuticals, Kardium, Konscious Foods, Notch Therapeutics, Precision Nanosystems, Semios, Sierra Oncology, STEMCELL, UBC, Unilab, Xenon Pharmaceuticals, Zymeworks

What’s the Damage so Far? Breaking Down the 2022 Layoffs in BC Tech

August 11, 2022 by Robert Lewis Leave a Comment

Several thousand Canadians employed in the technology sector have been laid off this year, as a brief post-Pandemic surge has quickly soured into a global downturn. Layoffs hail from a wide range of companies, including Ottawa’s Shopify and Toronto’s Clearco. In all, more than 400 tech firms in North America have laid off staff in 2022. Several […]

Filed Under: News Tagged With: Article, Dooly, Hootsuite, Thinkific, Unbounce, Zymeworks

Investment Firm Offers To Buy Zymeworks For USD $733 Million

April 28, 2022 by Techcouver Newsdesk Leave a Comment

Vancouver’s Zymeworks has received an unsolicited offer from investment firm All Blue Capital to acquire the publicly traded company for USD $10.50 per share, for a total of USD $773 million in cash. The proposal offers a share price more than twice the value at market close today. Dubai-based All Blue Capital currently owns close […]

Filed Under: News Tagged With: Zymeworks

New Zymeworks CEO Plans To Lay Off 25% Of Staff In 2022

January 20, 2022 by Techcouver Newsdesk Leave a Comment

Two weeks after being named the new CEO of Zymeworks, Kenneth Galbraith has announced major leadership changes and said the clinical-stage biopharmaceutical company will lay off at least 25% of its staff this year. Galbraith replaced Zymeworks co-founder Ali Tehrani, Ph.D., who has served as President and CEO since 2003. Dr. Tehrani will remain as […]

Filed Under: News Tagged With: Zymeworks

Zymeworks Announces Monster New Antibody Collaboration with Pharma Giant Merck

July 9, 2020 by Techcouver Newsdesk

Vancouver-headquartered Zymeworks has signed a new license agreement with longtime partner Merck granting the pharmaceutical  giant the right to develop additional multispecific antibody therapeutic candidates using Zymeworks’ Azymetric™ and EFECT™ platforms. Under the terms of the agreement, Zymeworks will provide Merck a worldwide, royalty-bearing license to research, develop and commercialize up to three new multispecific antibodies […]

Filed Under: News Tagged With: Zymeworks

Primary Sidebar

 
 

Stay Connected

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter

About Us

Techcouver provides real-time reporting and analysis of emerging technology news in Vancouver and throughout British … READ MORE... about About Us

Copyright © 2023 Incubate Ventures | Techtalent.ca · Decoder.ca · Calgary.tech · Fintech.ca · | Privacy

Privacy Policy